4
Changes in Ownership
IDEXX LABORATORIES INC /DE Filed Acc 0001567619-22-019388
President & CEO sold 13,230 shares at an average $382.49 ($5,060,319)
- President & CEO acquired 24,002 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
MAZELSKY JONATHAN JAY · President & CEO
Table I: Non-derivative
8 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-11-07 | Exercise or conversion : show line 1 in the form | +24,002 | $52.00 | $1,248,104 | 75,536.64 | D |
| 2022-11-07 | Sale : show line 2 in the form | −900 | $378.60 | $340,736 | 74,636.64 | D |
| 2022-11-07 | Sale : show line 3 in the form | −2,000 | $379.50 | $758,999 | 72,636.64 | D |
| 2022-11-07 | Sale : show line 4 in the form | −500 | $380.85 | $190,426 | 72,136.64 | D |
| 2022-11-07 | Sale : show line 5 in the form | −3,704 | $382.81 | $1,417,912 | 68,432.64 | D |
| 2022-11-07 | Sale : show line 6 in the form | −2,716 | $383.29 | $1,041,006 | 65,716.64 | D |
| 2022-11-07 | Sale : show line 7 in the form | −3,018 | $384.47 | $1,160,316 | 62,698.64 | D |
| 2022-11-07 | Sale : show line 8 in the form | −392 | $385.01 | $150,925 | 62,306.64 | D |
| Open-market sales · 13,230 sh · avg $382.49 · $5,060,319 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2022-11-07 | Exercise or conversion : show line 9 in the form Non-Qualified Stock Option (right-to-buy) | −24,002 | $52.00 | 2023-12-04 | 24,002 | 0 | D |
Loading xslF345X03/doc1.xml…